Oncology News

The FDA granted fast track designation to TH1902 for treatment of certain patients with sortilin-expressing cancers, according to the agent’s manufacturer.

Although colorectal cancer mortality has declined steadily since the 1940s, the long-term prognosis for patients with late-stage metastatic disease has remained relatively poor.

Long-term, regular use of aspirin before diagnosis appeared associated with lower colorectal cancer-specific mortality, according to results of an observational study published in Journal of the National Cancer Institute.

Individuals with obesity and high alcohol consumption, as well as other factors, were at higher risk for developing early-onset colorectal cancer, according to study results.

Delayed colonoscopy after an abnormal stool-based screening test was associated with increased risk for colorectal cancer, according to study results.

Population-based fecal immunochemical test screening was effective at reducing risk for advanced colorectal cancer and associated mortality, according to study results.

The organization Fight Colorectal Cancer is celebrating that the Removing Barriers to Colorectal Cancer Screening Act has been recently signed into law.

Terence M. Williams, MD, PhD, has been appointed chair of City of Hope’s department of radiation oncology.

Tislelizumab extended OS compared with chemotherapy for patients with previously treated advanced esophageal squamous cell carcinoma, according to topline data released by the agent’s manufacturer.

Black individuals have the highest incidence and mortality rates of colorectal cancer of any racial or ethnic group in the United States.